Evidence map›Paper›PMID 19817865›Full record

ArticleFEMS microbiology letters2009

Characterization of SgcE6, the flavin reductase component supporting FAD-dependent halogenation and hydroxylation in the biosynthesis of the enediyne antitumor antibiotic C-1027.

Steven G Van Lanen, Shuangjun Lin, Geoff P Horsman, Ben Shen

Open access · greenAbstract read
In one paragraph

Article in FEMS microbiology letters, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Steven G Van LanenDivision of Pharmaceutical Sciences, University of Wisconsin-Madison, 777 Highland Avemue, Madison, WI 53705, USA.
Shuangjun Lin
Geoff P Horsman
Ben Shen
University of Wisconsin–Madison · US

Funding

Zeeh Pharmaceutical Experimental StationU19CA113297 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI VAN CAMPEN, HANA · 2005 to 2009
$5.4M
Enediyne Biosynthesis and EngineeringR01CA078747 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEN, BEN · 1999 to 2015
$3.4M
Characterization of C-1027 Enediyne Polyketide SynthaseF32CA105984 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI VAN LANEN, STEVEN GARY · 2004 to 2006
$134k
NCI NIH HHS CA 1059845NCI NIH HHS CA 113297NCI NIH HHS CA 78747NCI NIH HHS F32 CA105984NCI NIH HHS R01 CA078747NCI NIH HHS U19 CA113297
6 · The paper itself

Abstract

The C-1027 enediyne antitumor antibiotic from Streptomyces globisporus possesses an (S)-3-chloro-5-hydroxy-beta-tyrosine moiety, the chloro- and hydroxy-substituents of which are installed by a flavin-dependent halogenase SgcC3 and monooxygenase SgcC, respectively. Interestingly, a single flavin reductase, SgcE6, can provide reduced flavin to both enzymes. Bioinformatics analysis reveals that, similar to other flavin reductases involved in natural product biosynthesis, SgcE6 belongs to the HpaC-like subfamily of the Class I flavin reductases. The present study describes the steady-state kinetic characterization of SgcE6 as a strictly NADH- and FAD-specific enzyme.

Indexed as

Amino Acid SequenceAminoglycosidesAntineoplastic AgentsBacterial ProteinsBiosynthetic PathwaysCluster AnalysisEnediynesFlavin-Adenine DinucleotideHalogenationHydroxylationKineticsMolecular Sequence DataNADOxidoreductasesPhylogenySequence HomologyAminoglycosidesAntineoplastic AgentsBacterial ProteinsC 1027EnediynesFlavin-Adenine DinucleotideNADOxidoreductases

Identifiers

PMID19817865
PMCPMC2767520
OpenAlexW2025423007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.